Fresenius Medical Care AG & Co. KGaA (FME) Given a €95.10 Price Target by J P Morgan Chase & Co Analysts

J P Morgan Chase & Co set a €95.10 ($111.88) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report sent to investors on Tuesday. The firm currently has a buy rating on the stock.

A number of other research firms have also commented on FME. Nord/LB set a €93.00 ($109.41) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, May 4th. S&P Global set a €88.00 ($103.53) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Wednesday, May 3rd. Kepler Capital Markets set a €95.00 ($111.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Wednesday, May 3rd. Commerzbank Ag set a €88.00 ($103.53) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Wednesday, May 3rd. Finally, Berenberg Bank set a €95.00 ($111.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Wednesday, May 3rd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have issued a buy rating to the company. Fresenius Medical Care AG & Co. KGaA currently has a consensus rating of Hold and an average target price of €88.21 ($103.78).

Fresenius Medical Care AG & Co. KGaA (ETR:FME) opened at 77.425 on Tuesday. The firm has a market cap of €23.76 billion and a PE ratio of 19.965. The firm’s 50-day moving average is €82.48 and its 200-day moving average is €81.13. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €70.82 and a 12 month high of €89.07.

WARNING: “Fresenius Medical Care AG & Co. KGaA (FME) Given a €95.10 Price Target by J P Morgan Chase & Co Analysts” was first reported by Community Financial News and is the property of of Community Financial News. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/12/fresenius-medical-care-ag-95-10-price-target-by-j-p-morgan-chase-co-analysts.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. KGaA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. KGaA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit